04:48 PM EDT, 07/14/2025 (MT Newswires) -- Anavex Life Sciences ( AVXL ) filed a registration statement late Monday for the sale of up $300 million of common shares from time to time.

The company plans to use the net proceeds for working capital and general corporate purposes.

Shares of the company fell 1.1% in recent after-hours activity.

Price: 11.35, Change: -0.13, Percent Change: -1.13